Progress in Neoadjuvant Therapy for Breast Cancer: Reviewing the Role of Immunotherapy, Endocrine and Anti-Her-2 Therapy
Overview
NA
Target Audience
NA
This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.
Faculty
Gregory Vidal, MD
Date of Release
May 14th, 2025
